Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
70.1%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 0.7Close
$ 0.18 - $ 1.57 52-Week Range
Ticker Information
Ticker
PSTVCompany Name
PLUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPLUS THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PSTV - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.73M | 70.1% | $ 5.32M |
| 3/31/2025 | $ 7.45M | 143.08% | $ 5.21M |
| 12/31/2024 | $ 3.72M | 63.94% | $ 5.82M |
| 9/30/2024 | $ 3.73M | 65.14% | $ 5.72M |
| 6/30/2024 | $ 3.75M | 68.16% | $ 5.51M |
| 3/31/2024 | $ 295K | 4.85% | $ 6.08M |
| 12/31/2023 | $ 395K | 8.04% | $ 4.91M |
| 9/30/2023 | $ 492K | 13.12% | $ 3.75M |
| 6/30/2023 | $ 578K | 22.37% | $ 2.58M |
| 3/31/2023 | $ 647K | 88.63% | $ 730K |
Key Performance Insights, Last 5 Years
- PLUS THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 82.63%.
- Over the past 5 years, PLUS THERAPEUTICS INC's average Int. Exp. % has been 194.6%.
- The median Int. Exp. % for PLUS THERAPEUTICS INC during this period was 70.1%
- PLUS THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 1063.01%.
- The lowest Int. Exp. % recorded by PLUS THERAPEUTICS INC in the same timeframe 4.85%
PLUS THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for PLUS THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 1.23M ] / Revenues [ $ 1.49M ]
(=) Int. Exp. % [ 82.63% ] PSTV - Interest Expense Margin, Last 5 years
4.85%
Minimum
Mar 31, 2024
1063.01%
Maximum
Sep 30, 2022
194.6%
Average
70.1%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |